These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8859021)

  • 1. In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.
    Lacal PM; D'Atri S; Orlando L; Bonmassar E; Graziani G
    J Pharmacol Exp Ther; 1996 Oct; 279(1):416-22. PubMed ID: 8859021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines.
    Tentori L; Graziani G; Gilberti S; Lacal PM; Bonmassar E; D'Atri S
    Leukemia; 1995 Nov; 9(11):1888-95. PubMed ID: 7475280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia.
    Graziani G; Faraoni I; Grohmann U; Bianchi R; Binaglia L; Margison GP; Watson AJ; Orlando L; Bonmassar E; D'Atri S
    Cancer Res; 1995 Dec; 55(24):6231-6. PubMed ID: 8521419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
    Tentori L; Orlando L; Lacal PM; Benincasa E; Faraoni I; Bonmassar E; D'Atri S; Graziani G
    Mol Pharmacol; 1997 Aug; 52(2):249-58. PubMed ID: 9271347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase.
    Tentori L; Lacal PM; Benincasa E; Franco D; Faraoni I; Bonmassar E; Graziani G
    J Pharmacol Exp Ther; 1998 May; 285(2):884-93. PubMed ID: 9580640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazene compounds: mechanism of action and related DNA repair systems.
    Marchesi F; Turriziani M; Tortorelli G; Avvisati G; Torino F; De Vecchis L
    Pharmacol Res; 2007 Oct; 56(4):275-87. PubMed ID: 17897837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.
    Spiro T; Liu L; Gerson S
    Forum (Genova); 2000; 10(3):274-85. PubMed ID: 11007934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro.
    Turriziani M; Caporaso P; Bonmassar L; Buccisano F; Amadori S; Venditti A; Cantonetti M; D'Atri S; Bonmassar E
    Pharmacol Res; 2006 Apr; 53(4):317-23. PubMed ID: 16412662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
    Liu L; Markowitz S; Gerson SL
    Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity.
    Alvino E; Pepponi R; Pagani E; Lacal PM; Nunziata C; Bonmassar E; D'Atri S
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1292-300. PubMed ID: 10565854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system.
    Pagani E; Pepponi R; Fuggetta MP; Prete SP; Turriziani M; Bonmassar L; Lacal PM; Falcinelli S; Passarelli F; Guadagni F; Alvino E; D'Atri S
    J Chemother; 2003 Apr; 15(2):173-83. PubMed ID: 12797396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mammalian cells against chloroethylating agent toxicity by an O6-benzylguanine-resistant mutant of human O6-alkylguanine-DNA alkyltransferase.
    Hickson I; Fairbairn LJ; Chinnasamy N; Dexter TM; Margison GP; Rafferty JA
    Gene Ther; 1996 Oct; 3(10):868-77. PubMed ID: 8908500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin increases sensitivity of human leukemic blasts to triazene compounds.
    Piccioni D; D'Atri S; Papa G; Caravita T; Franchi A; Bonmassar E; Graziani G
    J Chemother; 1995 Jun; 7(3):224-9. PubMed ID: 7562019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of purified human O6-alkylguanine-DNA alkyltransferase by alkylating agents or alkylated DNA.
    Brent TP
    Cancer Res; 1986 May; 46(5):2320-3. PubMed ID: 2938727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
    Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
    No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: studies with blasts of leukaemic patients.
    D'Atri S; Piccioni D; Castellano A; Tuorto V; Franchi A; Lu K; Christiansen N; Frankel S; Rustum YM; Papa G
    Ann Oncol; 1995 Apr; 6(4):389-93. PubMed ID: 7619755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivation of O6-alkylguanine-DNA alkyltransferase.
    Gerson SL; Trey JE; Miller K
    Cancer Res; 1988 Mar; 48(6):1521-7. PubMed ID: 3162197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.
    Dolan ME; Morimoto K; Pegg AE
    Cancer Res; 1985 Dec; 45(12 Pt 1):6413-7. PubMed ID: 4063990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of the human O6-alkylguanine-DNA alkyltransferase containing arginine at codon 160 to inactivation by O6-benzylguanine.
    Edara S; Kanugula S; Goodtzova K; Pegg AE
    Cancer Res; 1996 Dec; 56(24):5571-5. PubMed ID: 8971155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl)1-nitrosourea, and cisplatin.
    Pepponi R; Marra G; Fuggetta MP; Falcinelli S; Pagani E; Bonmassar E; Jiricny J; D'Atri S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):661-8. PubMed ID: 12538819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.